These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10146407)

  • 1. An accurate assay for platelet factor 3.
    Speck RE
    Am Clin Lab; 1993 Sep; 12(9):16-8. PubMed ID: 10146407
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of three prothrombin time and activated partial thromboplastin time reagent systems on the MLA 700 coagulation analyzer.
    Kritikos VG; Melhem MF
    Clin Lab Sci; 1993; 6(5):302-7. PubMed ID: 10146556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of methods of studying hemostasis].
    Tarasova LN; Ivashkina EP; Platonova GK
    Lab Delo; 1989; (5):18-21. PubMed ID: 2473251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of six activated partial thromboplastin time reagents: intrinsic system factors' sensitivity and responsiveness.
    Hales SC; Johnson GS; Wagner D
    Clin Lab Sci; 1990; 3(3):194-6. PubMed ID: 10149038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet factor 3 availability test: an effective screening test for types 1 and 2 von Willebrand disease.
    Gupta PK; Ahmed R; Kannan M; Chatterjee T; Choudhry VP; Saxena R
    Ann Hematol; 2004 Jul; 83(7):489-90. PubMed ID: 15052373
    [No Abstract]   [Full Text] [Related]  

  • 7. A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.
    Benattar N; Schved JF; Biron-Andréani C
    Thromb Haemost; 2000 Jun; 83(6):967-8. PubMed ID: 10896260
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the activated partial thromboplastin time suitable to screen for von Willebrand factor deficiencies?
    Lippi G; Franchini M; Poli G; Salvagno GL; Montagnana M; Guidi GC
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):361-4. PubMed ID: 17473578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimeric analysis in diagnosis of vWD variants in Indians.
    Gupta PK; Kumar H; Saxena R
    Indian J Pathol Microbiol; 2007 Jul; 50(3):636-9. PubMed ID: 17883169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of factor VIII deficiency.
    Verbruggen B; Meijer P; Novákova I; Van Heerde W
    Haemophilia; 2008 Jul; 14 Suppl 3():76-82. PubMed ID: 18510526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
    Mischke R; Junker J; Deegen E
    Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of anti-HCV detection kits using recombinant antigens derived from various HCV regions].
    Deng P; Zhang HJ; Li Y; Liu W; Wang QP; Chu JH; Zhang HQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):354-5. PubMed ID: 15650788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Re-evaluation of HCV Ab detection kits approved for marketing in Japan].
    Rinsho Byori; 2002 Mar; 50(3):313-7. PubMed ID: 11985063
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of daptomycin with two recombinant thromboplastin reagents leads to falsely prolonged patient prothrombin time/International Normalized Ratio results.
    Webster PS; Oleson FB; Paterson DL; Arkin CF; Mangili A; Craven DE; Adcock DM; Lindfield KC; Knapp AG; Martone WJ
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):32-8. PubMed ID: 18180613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies.
    Sukovaty RL; Lee JW; Fox J; Toney K; Papac DI; Grover TA; Wells DS
    J Pharm Biomed Anal; 2006 Sep; 42(2):261-71. PubMed ID: 16765549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of platelets and platelet-derived material on the activated partial thromboplastin time (Cephotest) coagulation test.
    Mendelsohn EE; Solum NO; Brosstad F
    Scand J Clin Lab Invest; 2005; 65(4):321-32. PubMed ID: 16076687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study.
    Toulon P; Smirnov M; Triscott M; Safa O; Biguzzi E; Bouziane K; Tripodi A
    Thromb Res; 2009 May; 124(1):137-43. PubMed ID: 19157524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tests for BSE evaluated. Bovine spongiform encephalopathy.
    Moynagh J; Schimmel H
    Nature; 1999 Jul; 400(6740):105. PubMed ID: 10408430
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M; Hillarp A; Svensson P
    Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.